# Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.

> **NCT03260283** · PHASE2,PHASE3 · COMPLETED · sponsor: **Saint Savvas Anticancer Hospital** · enrollment: 104 (actual)

## Conditions studied

- Low Dose of Pethidine for Subarachnoid Anesthesia

## Interventions

- **DRUG:** Pethidine hydrochloride
- **DRUG:** Ropivacaine HCl Inj 7.5 MG/ML
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03260283
- **Lead sponsor:** Saint Savvas Anticancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-16
- **Primary completion:** 2018-11-29
- **Final completion:** 2019-12-31
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03260283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03260283, "Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03260283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*